These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 947135)

  • 1. Studies on the conversion of oestradiol linked to a cytostatic agent (Estracyt) in various rat tissues.
    Hoisaeter PA
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):661-72. PubMed ID: 947135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oestradiol-3N-bis-(2-chloroethyl)carbamate-17beta-phosphate (estracyt) on the 5alpha-reductase in the rat ventral prostate.
    Hoisaeter PA
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):188-98. PubMed ID: 1173982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of 3H-thymidine and 14C-amino acids into the ventral prostate after in vivo treatment with estradiol-3N-BIS(2-chloroethyl)carbamate-17 beta-phosphate (Estracyt) and its estrogen and cytostatic parts.
    Hoisaeter PA
    Invest Urol; 1976 Sep; 14(2):85-92. PubMed ID: 972011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of testosterone on estracyt localization in rat prostate.
    Catane R; Mittelman A; Murphy GP; Sandberg AA
    Oncology; 1980; 37(5):357-9. PubMed ID: 7443167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Andersson SB; Gunnarsson PO; Nilsson T; Forshell GP
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):149-54. PubMed ID: 7274309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic studies of 3H-estramustine in the rat ventral prostate.
    Appelgren LE; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):368-74. PubMed ID: 726901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
    Björk P; Jönsson U; Andrén-Sandberg A
    Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol.
    Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone-induced DNA synthesis in cultured rat ventral prostate: effects of estracyt and its derivatives.
    Buchanan LJ; Riches AC
    Br J Cancer; 1987 Jan; 55(1):47-51. PubMed ID: 3814475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of retention of estramustine in the rat prostate and results of a clinical trial of Estracyt in Japan.
    Yamanaka H; Imai K; Yuasa H; Shida K
    Prostate; 1981; Suppl 1():95-102. PubMed ID: 7043423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence in rat and human prostate of proteins that bind steroid-cytostatic complexes.
    Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
    Prog Clin Biol Res; 1981; 75A():391-407. PubMed ID: 7339627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hydrolysis of estramustine phosphate; in vitro studies.
    Gunnarsson O; Andersson SB; Johansson SA
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):395-402. PubMed ID: 6673977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estramustine-binding protein in rat and human prostate.
    Forsgren B
    Scand J Urol Nephrol Suppl; 1988; 107():56-8. PubMed ID: 3287598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer.
    Sandberg AA
    Urology; 1984 Jun; 23(6 Suppl):11-21. PubMed ID: 6375075
    [No Abstract]   [Full Text] [Related]  

  • 17. In vivo interaction between steroidal alkylating agents and oestrogen receptors in rabbit uteri.
    Asai M; Takeuchi H; Okada H
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):173-80. PubMed ID: 579532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N; Kirdani RY; Murphy GP; Sandberg AA
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
    Forshell GP; Müntzing J; Ek A; Lindstedt E; Dencker H
    Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on phenolic steroids in human subjects. XIV. Fate of a nitrogen mustard of estradiol-17beta.
    Kirdani RY; Mittelman A; Murphy GP; Sandberg AA
    J Clin Endocrinol Metab; 1975 Aug; 41(2):305-18. PubMed ID: 808555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.